RIPK3 and chronic obstructive pulmonary disease: Mizumura et al. [112] first demonstrated that necroptosis through RIPK3 activation promotes the pathogenesis of COPD in CS-exposed pulmonary epithelial cultured cells and that cell death response reduces in the presence of necroptosis inhibitor, Nec-1.